查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1743747

兒科介入性心臟病學市場－全球產業規模、佔有率、趨勢、機會和預測（按設備類型、按程序、按地區和競爭細分，2020-2030 年）

Pediatric Interventional Cardiology Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device Type, By Procedure, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球兒科介入性心臟病學市場價值 24.1 億美元，預計將經歷顯著成長，到 2030 年的複合年成長率為 6.72%。該市場專注於診斷和治療兒童心臟缺陷的微創手術，為傳統開胸心臟手術提供更安全的替代方案。在影像、導管插入和設備創新技術進步的推動下，介入性心臟病學擴大用於治療兒科族群的先天性和後天性心臟病。先天性心臟缺陷 (CHD) 盛行率高，尤其是在美國等已開發國家，凸顯了對兒科心血管護理的迫切需求。增強的早期檢測技術和長期照護方法在改善患者預後方面發揮著至關重要的作用，有助於市場快速成長和全球擴張。

市場概覽
預測期 2026-2030
2024年市場規模 24.1億美元
2030年市場規模 35.3億美元
2025-2030 年複合年成長率 6.72%
成長最快的領域 經導管心臟瓣膜
最大的市場 北美洲

關鍵市場促進因素

先天性心臟病（CHD）發生率上升

主要市場挑戰

獲得專科護理的機會有限

主要市場趨勢

經導管瓣膜治療

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球兒科介入性心臟病學市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依設備類型（封堵器、經導管心臟瓣膜、動脈粥狀硬化斑塊切除設備、導管、球囊、支架、其他）
    • 依手術（導管瓣膜植入術、先天性心臟缺陷矯正術、血管成形術、冠狀動脈血栓切除術等）
    • 按地區
    • 按公司分類（2024）
  • 產品市場圖
    • 依設備類型
    • 按程式
    • 按地區

第6章：北美兒科介入性心臟病學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲兒科介入性心臟病學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第8章：亞太地區兒科介入性心臟病學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國

第9章：南美洲兒科介入性心臟病學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲兒科介入性心臟病學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Abbott Laboratories Inc
  • Biotronik Inc
  • Boston Scientific Corporation
  • Canon Medical Systems Corp
  • Cardinal Health Inc
  • Cordis Corp
  • Edwards Lifesciences LLC
  • GE Healthcare Inc
  • Medtronic Inc
  • Siemens Healthineers AG

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16211

The Global Pediatric Interventional Cardiology Market was valued at USD 2.41 billion in 2024 and is forecast to experience significant growth, registering a CAGR of 6.72% through 2030. This market focuses on minimally invasive procedures for diagnosing and treating heart defects in children, offering safer alternatives to conventional open-heart surgery. Driven by technological advancements in imaging, catheterization, and device innovation, interventional cardiology is increasingly used to manage congenital and acquired heart conditions in pediatric populations. High prevalence rates of congenital heart defects (CHDs), particularly in developed nations such as the United States, underscore the urgent demand for pediatric cardiovascular care. Enhanced early detection techniques and long-term care approaches are playing a crucial role in advancing patient outcomes, contributing to the market's rapid growth and global expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.41 Billion
Market Size 2030USD 3.53 Billion
CAGR 2025-20306.72%
Fastest Growing SegmentTranscatheter Heart Valves
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Congenital Heart Diseases (CHD)

The increasing prevalence of congenital heart diseases (CHDs) is a major force driving the Global Pediatric Interventional Cardiology Market. These structural and functional heart abnormalities, present at birth, often necessitate early and specialized medical intervention. CHDs can range from minor defects to life-threatening conditions, requiring timely diagnosis and treatment. According to the CDC, CHDs affect nearly 1% of all newborns in the United States-around 40,000 infants annually. Among these, approximately 25% are diagnosed with critical heart defects that require surgical or interventional procedures within the first year of life. Technological advancements in fetal and postnatal diagnostics-such as echocardiography, ultrasound, and genetic screening-enable earlier and more accurate detection of CHDs, allowing for timely and effective treatment. This growing burden of CHD globally is accelerating the adoption of pediatric interventional cardiology solutions.

Key Market Challenges

Limited Access to Specialized Care

Access to specialized pediatric cardiac care remains a key challenge, particularly in underserved and low-income regions. Many healthcare facilities in these areas lack the necessary infrastructure, trained personnel, and diagnostic capabilities to provide early and effective interventional cardiac treatments for children. This gap limits the reach of life-saving procedures and contributes to delayed treatment and poorer outcomes in affected pediatric populations.

Key Market Trends

Transcatheter Valve Therapies

Transcatheter valve interventions are emerging as a transformative trend in pediatric cardiology. These minimally invasive procedures allow for the repair or replacement of heart valves without the need for open-heart surgery, significantly reducing recovery time and procedural risk. The adoption of transcatheter valve technologies reflects a broader shift toward less invasive cardiac interventions in children, improving both safety and clinical outcomes in complex cases.

Key Market Players

  • Abbott Laboratories Inc
  • Biotronik Inc
  • Boston Scientific Corporation
  • Canon Medical Systems Corp
  • Cardinal Health Inc
  • Cordis Corp
  • Edwards Lifesciences LLC
  • GE Healthcare Inc
  • Medtronic Inc
  • Siemens Healthineers AG

Report Scope:

In this report, the Global Pediatric Interventional Cardiology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pediatric Interventional Cardiology Market, By Device Type:

  • Closure Devices
  • Transcatheter Heart Valves
  • Atherectomy Devices
  • Catheters
  • Balloons
  • Stents
  • Others

Pediatric Interventional Cardiology Market, By Procedure:

  • Catheter-Based Valve Implantation
  • Congenital Heart Defect Correction
  • Angioplasty
  • Coronary Thrombectomy
  • Others

Pediatric Interventional Cardiology Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Interventional Cardiology Market.

Available Customizations:

Global Pediatric Interventional Cardiology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pediatric Interventional Cardiology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 5.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Device Type
    • 5.3.2. By Procedure
    • 5.3.3. By Region

6. North America Pediatric Interventional Cardiology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 6.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pediatric Interventional Cardiology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device Type
        • 6.3.1.2.2. By Procedure
    • 6.3.2. Canada Pediatric Interventional Cardiology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device Type
        • 6.3.2.2.2. By Procedure
    • 6.3.3. Mexico Pediatric Interventional Cardiology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device Type
        • 6.3.3.2.2. By Procedure

7. Europe Pediatric Interventional Cardiology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 7.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pediatric Interventional Cardiology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device Type
        • 7.3.1.2.2. By Procedure
    • 7.3.2. United Kingdom Pediatric Interventional Cardiology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device Type
        • 7.3.2.2.2. By Procedure
    • 7.3.3. France Pediatric Interventional Cardiology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device Type
        • 7.3.3.2.2. By Procedure
    • 7.3.4. Italy Pediatric Interventional Cardiology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device Type
        • 7.3.4.2.2. By Procedure
    • 7.3.5. Spain Pediatric Interventional Cardiology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device Type
        • 7.3.5.2.2. By Procedure

8. Asia-Pacific Pediatric Interventional Cardiology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 8.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Pediatric Interventional Cardiology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device Type
        • 8.3.1.2.2. By Procedure
    • 8.3.2. Japan Pediatric Interventional Cardiology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device Type
        • 8.3.2.2.2. By Procedure
    • 8.3.3. India Pediatric Interventional Cardiology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device Type
        • 8.3.3.2.2. By Procedure
    • 8.3.4. Australia Pediatric Interventional Cardiology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device Type
        • 8.3.4.2.2. By Procedure
    • 8.3.5. South Korea Pediatric Interventional Cardiology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device Type
        • 8.3.5.2.2. By Procedure

9. South America Pediatric Interventional Cardiology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 9.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Pediatric Interventional Cardiology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device Type
        • 9.3.1.2.2. By Procedure
    • 9.3.2. Argentina Pediatric Interventional Cardiology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device Type
        • 9.3.2.2.2. By Procedure
    • 9.3.3. Colombia Pediatric Interventional Cardiology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device Type
        • 9.3.3.2.2. By Procedure

10. Middle East and Africa Pediatric Interventional Cardiology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 10.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Pediatric Interventional Cardiology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device Type
        • 10.3.1.2.2. By Procedure
    • 10.3.2. Saudi Arabia Pediatric Interventional Cardiology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device Type
        • 10.3.2.2.2. By Procedure
    • 10.3.3. UAE Pediatric Interventional Cardiology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device Type
        • 10.3.3.2.2. By Procedure
    • 10.3.4. Kuwait Pediatric Interventional Cardiology Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Device Type
        • 10.3.4.2.2. By Procedure

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Abbott Laboratories Inc
    • 14.1.1. Business Overview
    • 14.1.2. Product Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Biotronik Inc
  • 14.3. Boston Scientific Corporation
  • 14.4. Canon Medical Systems Corp
  • 14.5. Cardinal Health Inc
  • 14.6. Cordis Corp
  • 14.7. Edwards Lifesciences LLC
  • 14.8. GE Healthcare Inc
  • 14.9. Medtronic Inc
  • 14.10. Siemens Healthineers AG

15. Strategic Recommendations

16. About Us & Disclaimer